SCHEMBL1647101

SCHEMBL1647101

COc1ccc(O)cc1C=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.60
CAPN1 P07384 1/20 0.57
ERN1 O75460 7/20 0.56
ALDH1A1 P00352 5/20 0.55
TDP1 Q9NUW8 2/20 0.55
TSHR P16473 2/20 0.55
KDM4E B2RXH2 1/20 0.55
TRIM24 O15164 2/20 0.52
TRIM33 Q9UPN9 2/20 0.52
TYR P14679 1/20 0.52
TLR2 O60603 1/20 0.52
TLR1 Q15399 1/20 0.52
TLR6 Q9Y2C9 1/20 0.52
AOX1 Q06278 1/20 0.52
TUBB1 Q9H4B7 1/20 0.50
MAOB P27338 1/20 0.50
APP P05067 2/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.47
ALDH5A1 P51649 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29953580 1.00 BACE1 (0.60) BACE1CAPN1ERN1ALDH1A1TDP1
SCHEMBL19792588 0.85 ERN1 (0.71) ERN1ALDH1A1KDM4EMAPT
SCHEMBL37462 0.84 ALDH1A1 (0.63) CAPN1ERN1ALDH1A1TDP1TSHR
SCHEMBL4034867 0.79 ALDH1A1 (0.51) BACE1CAPN1ERN1ALDH1A1TSHR
SCHEMBL6703981 0.79 CYP3A4 (0.44) BACE1CAPN1ERN1ALDH1A1TDP1
SCHEMBL20152991 0.78 BACE1 (0.77) BACE1CAPN1ALDH1A1TDP1KDM4E
SCHEMBL9560068 0.78 NR5A1 (0.51) ALDH1A1HPGD
SCHEMBL1662997 0.78 ALDH1A1 (0.70) ALDH1A1TDP1TSHRKDM4ETRIM24
SCHEMBL29392394 0.78 ALDH1A1 (0.71) ERN1ALDH1A1TDP1TSHRKDM4E
SCHEMBL419596 0.78 ALDH1A1 (0.57) ERN1ALDH1A1TDP1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12195489-B2 Spiro-bisphosphorous compound, and preparation and application thereof GUANGDONG OXO CHEM LTD. (CN) 2025-01-14 US claimed
US-20230148641-A1 FLAVOR COMPOSITION FIRMENICH SA (CH) 2023-05-18 US claimed
EP-4125427-A1 FLAVOR COMPOSITION Firmenich SA (CH) 2023-02-08 EP claimed
CN-115279206-A Flavor composition 弗门尼舍有限公司 2022-11-01 CN claimed
CN-115246765-A Preparation method and application of spirocyclic diphenol and diphosphonite thereof 惠州凯特立斯科技有限公司 2022-10-28 CN claimed
US-20220242891-A1 SPIRO-BISPHOSPHOROUS COMPOUND, AND PREPARATION AND APPLICATION THEREOF GUANGDONG OXO CHEM LTD. (CN) 2022-08-04 US claimed
WO-2021198199-A1 FLAVOR COMPOSITION FIRMENICH SA (CH) 2021-10-07 WO claimed
CN-111747685-A Environment-friendly odorless asphalt mixture and preparation method thereof 上海佳砼新材料科技发展有限公司 2020-10-09 CN claimed
CN-111607243-A Environment-friendly odorless asphalt composition and preparation method thereof 上海佳砼新材料科技发展有限公司 2020-09-01 CN claimed
US-12577217-B2 15-PGDH inhibitor KYORIN PHARMACEUTICAL CO., LTD. (JP) 2026-03-17 US disclosed
US-12534425-B2 Phenalkylamines and methods of treating mood disorders GILGAMESH PHARMACEUTICALS, INC. (US) 2026-01-27 US disclosed
US-20260021061-A1 ARIADNE AND ANALOGS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROMUSCLAR DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2026-01-22 US disclosed
US-20250353874-A1 GLUCOCORTICOID RECEPTOR AGONISTS LILLY CO ELI (US) 2025-11-20 US disclosed
US-20250326744-A1 PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FUJIFILM CORPORATION (JP) 2025-10-23 US disclosed
US-4766121-A NOT AFFECTING THE HEART SMITH KLINE & FRENCH LABORATORIES LTD. (GB) 1988-08-23 US disclosed
CN-86100894-A Process for the preparation of compounds 1986-09-03 CN disclosed
EP-0188351-A2 Chemical compounds SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1986-07-23 EP disclosed
EP-0008277-B1 BENZOPYRANO DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING THE COMPOUNDS AND COMPOSITIONS Technobiotic Ltd. (CH) 1981-09-02 EP disclosed
US-4272535-A 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents SCHERING CORPORATION (US) 1981-06-09 US disclosed
EP-0008277-A1 Benzopyrano derivatives, pharmaceutical compositions containing them and processes for preparing the compounds and compositions Technobiotic Ltd. (CH) 1980-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577217-B2 15-PGDH inhibitor PTGDR, ADH1A, ADRA1A BACE1 3750/4885CAPN1 2955/4885ERN1 2225/4885
US-12195489-B2 Spiro-bisphosphorous compound, and preparation and application thereof SOST, BPGM, PFKFB3 BACE1 4577/4885CAPN1 3936/4885ERN1 4071/4885
US-20250353874-A1 GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, NR3C2, MC2R BACE1 2495/4885CAPN1 3943/4885ERN1 1650/4885
US-20220242891-A1 SPIRO-BISPHOSPHOROUS COMPOUND, AND PREPARATION AND APPLICATION THEREOF SOST, BPGM, PFKFB3 BACE1 4577/4885CAPN1 3936/4885ERN1 4071/4885
US-12534425-B2 Phenalkylamines and methods of treating mood disorders PNMT, SLC6A2, HTR2C BACE1 2013/4885CAPN1 4662/4885ERN1 3912/4885
US-20250326744-A1 PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION ABCB11, ABCC1, SLC11A2 BACE1 2965/4885CAPN1 1895/4885ERN1 3094/4885
US-20260021061-A1 ARIADNE AND ANALOGS FOR THE TREATMENT OF NEUROLOGICAL AND NEUROMUSCLAR DISORDERS ATXN2, HCRTR2, CDR2 BACE1 1486/4885CAPN1 2076/4885ERN1 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.